Kathleen Weisel
Impact in
-
- Psoriasis: Treatment and Pathogenesis
- interferon and immune responses
- Phagocytosis and Immune Regulation
-
- Inflammatory Bowel Disease
Papers in
-
- Immunodeficiency and Autoimmune Disorders 4
- Psoriasis: Treatment and Pathogenesis 2
- Genetics 4
- Inflammatory Bowel Disease 4
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Debra Tompson (3 shared papers)Monica Simeoni (2 shared papers)Paul P. Tak (2 shared papers)John Bertin (2 shared papers)Nicola Scott (2 shared papers)Scott B. Berger (2 shared papers)Silvio Danese (5 shared papers)Tadakazu Hisamatsu (4 shared papers)
- Journals
- The American Journal of Gastroenterology (2 papers)Journal of Crohn s and Colitis (2 papers)Gastroenterology (2 papers)Human Vaccines & Immunotherapeutics (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Kathleen Weisel
13 papers receiving 412 citations
Kathleen Weisel's Hit Papers
Peers
Comparison fields: 5 of 54
- Immunology 196
- Genetics 143
- Hematology 51
- Epidemiology 119
- Molecular Biology 200
Countries citing papers authored by Kathleen Weisel
This map shows the geographic impact of Kathleen Weisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Weisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Weisel more than expected).
Fields of papers citing papers by Kathleen Weisel
This network shows the impact of papers produced by Kathleen Weisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Weisel. The network helps show where Kathleen Weisel may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathleen Weisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study Hit paper breakdown → | 2022 | 132 |
| 2 | 2017 | 106 | |
| 3 | 2021 | 63 | |
| 4 | 2020 | 59 | |
| 5 | 2013 | 29 | |
| 6 | 2022 | 18 | |
| 7 | HIGH CUT-OFF HAEMODIALYSIS (HCO-HD) DOES NOT IMPROVE OUTCOMES IN MYELOMA CAST NEPHROPATHY: RESULTS OF EUROPEAN TRIAL OF FREE LIGHT CHAIN REMOVAL BY EXTENDED HAEMODIALYSIS IN CAST NEPHROPATHY (EULITE) | 2016 | 5 |
| 8 | 2021 | 4 | |
| 9 | 2025 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2015 | 1 |
About Kathleen Weisel
Kathleen Weisel is a scholar working on Immunology, Genetics, Molecular Biology, Genetics and Oncology, having authored 13 papers that have together received 424 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), NF-κB Signaling Pathways (2 papers), Rheumatoid Arthritis Research and Therapies (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Immunology (196 citations), Genetics (143 citations), Hematology (51 citations), Epidemiology (119 citations) and Molecular Biology (200 citations). Kathleen Weisel has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Debra Tompson, Monica Simeoni, Paul P. Tak, John Bertin, Nicola Scott, Scott B. Berger, Silvio Danese, Tadakazu Hisamatsu, Mary Ellen Frustaci and Brian G. Feagan. Their work appears in journals such as The American Journal of Gastroenterology, Journal of Crohn s and Colitis, Gastroenterology, Human Vaccines & Immunotherapeutics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.